Welgene Biotech Co.,Ltd. (TPEX:6661)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
18.60
-0.35 (-1.85%)
Nov 4, 2025, 1:30 PM CST
-1.85%
Market Cap441.62M
Revenue (ttm)346.12M
Net Income (ttm)2.30M
Shares Out23.30M
EPS (ttm)0.10
PE Ratio192.09
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume8,000
Average Volume22,586
Open18.65
Previous Close18.95
Day's Range18.60 - 18.65
52-Week Range16.80 - 28.50
Beta0.32
RSI32.11
Earnings DateNov 7, 2025

About Welgene Biotech

Welgene Biotech Co.,Ltd. provides genetic testing services. The company offers research services, including sequencing, microarray, qPCR verification, nucleic acid extraction/QC, LCM single cell experiment, and bioinformatics analysis services; and Cytoscan, an array-based comparative genomic hybridization. It also provides reagents, consumable supplies, and instruments, as well as software services. The company was founded in 2003 and is based in Taipei City, Taiwan. [Read more]

Sector Healthcare
Founded 2003
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 6661
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.